Search Results - "Urbini, B."

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) by FRANCESCHI, E, CAVALLO, G, TALLINI, G, CRINO, L, BRANDES, A. A, LONARDI, S, MAGRINI, E, TOSONI, A, GROSSO, D, SCOPECE, L, BLATT, V, URBINI, B, PESSION, A

“…To investigate the role of gefitinib in patients with high-grade gliomas (HGGs), a phase II trial (1839IL/0116) was conducted in patients with disease…”
Get full text

Efficacy of anti-EGFR antibodies combined with chemotherapy for elderly patients with RAS wild-type metastatic colorectal cancer: a systematic review and metanalysis by Carandina, I., Belluomini, L., Bonetti, F., Urbini, B., Daniel, F., Lancia, F., Martella, L.R., Toma, I., Moretti, A., Bannò, E., Nisi, C., Da Ros, L., Frassoldati, A.

Get full text

Efficacy and safety of immune checkpoint inhibitor nivolumab and radiotherapy combination in advanced NSCLC by Belluomini, L., Fiorica, F., Stefanelli, A., Santini, A., Urbini, B., Daniel, F., Martella, L.R., Toma, I., Lancia, F., Moretti, A., Bannò, E., Giorgi, C., Frassoldati, A.

Get full text

Gender and MGMT methylation in glioblastoma patients: interactions in the PERNO prospective study by Franceschi, E., Tosoni, A., Depenni, R., Urbini, B., Faedi, M., Michiara, M., Biasini, C., Giombelli, E., Pavesi, G., Zanelli, F., Cavallo, M.A., Tosatto, L., Fioravanti, A., Zunarelli, E., Lanza, G., Bartolini, D., Silini, E.M., Brandes, A.A.

Get full text

The Impact of the Introduction of Irinotecan and Oxaliplatin on the Outcome of Patients with Advanced Colorectal Cancer by Lelli, G., Carandina, I., Urbini, B., Guarino, S., Modonesi, C., Pedriali, M.

“…The effectiveness of oxaliplatin and irinotecan in advanced colorectal cancer therapy has been shown by many randomized clinical trials. We developed a…”
Get full text

Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation by ARPINATI, M, CHIRUMBOLO, G, RONDELLI, D, URBINI, B, MARTELLI, V, STANZANI, M, FALCIONI, S, BONIFAZI, F, BANDINI, G, TUNA, S, BACCARANI, M

“…TH2-inducing dendritic cells (DC2) are commonly identified as negative for lineage markers and positive for HLA-DR and CD123 expression. More recently, normal…”
Get full text

The Role of Cetuximab in Pre-Treated Refractory Patients with Metastatic Colorectal Cancer: Outcome Study in Clinical Practice by Lelli, G., Cataldo, S., Carandina, I., Urbini, B., Bonetti, F., Marzola, M., Biasco, G., Pantaleo, M.A., Brandes, A., Calandri, C., Ravaioli, E., Nanni, O., Boni, C., Banzi, C., Negri, F., Panetta, A., Di Fabio, F., Turci, D.

“…We carried out a multicentric retrospective study on cetuximab + chemotherapy in pre-treated refractory patients outside clinical protocols, by registering the…”
Get full text

Cryptococcal meningitis during front-line chemotherapy for acute lymphoblastic leukemia by Urbini, B, Castellini, C, Rondelli, R, Prete, A, Pierinelli, S, Pession, A

Get full text

Efficacy of anti-EGFR antibodies combined with chemotherapy for elderly patients with RAS wild-type metastatic colorectal cancer: A systematic review and metanalysis by Belluomini, L., Carandina, I., Bonetti, F., Urbini, B., Daniel, F., Lancia, F., Martella, L.R., Toma, I., Moretti, A., Bannò, E., Nisi, C., Da Ros, L., Frassoldati, A.

Get full text

Next Generation Sequencing mutational analysis in “Triple Positive” breast cancer by Indelli, M., Da Ros, L., Urbini, B., Ravaioli, N., Nisi, C., Moretti, A., Negrini, M., Frassoldati, A.

Get full text

The prognostic role of gender and MGMT methylation status in glioblastoma patients: The female power by Tosoni, A., Franceschi, E., Depenni, R., Urbini, B., Faedi, M., Michiara, M., Biasini, C., Giombelli, E., Pavesi, G., Zanelli, F., Cavallo, M.A., Tosatto, L., Fioravanti, A., Zunarelli, E., Lanza, G., Bartolini, D., Silini, E.M., Brandes, A.A.

Get full text

Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation by Arpinati, Mario, Chirumbolo, Gabriella, Urbini, Benedetta, Perrone, Giulia, Rondelli, Damiano, Anasetti, Claudio

“…Dendritic cells (DC) may play an important role in the pathogenesis of alloimmune reactions, such as graft-vs.-host disease after allogeneic hematopoietic stem…”
Get full text

Gefitinib (ZD1839) treatment for adult patients with progressive high-grade gliomas (HGG): An open label, single-arm, phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) by Franceschi, E., Lonardi, S., Tosoni, A., Grosso, D., Scopece, L., Berzioli, C., Urbini, B., Cavallo, G., Crinò, L., Brandes, A. A.

“…Abstract only…”
Get full text

Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage by Re, Francesca, Arpinati, Mario, Testoni, Nicoletta, Ricci, Paolo, Terragna, Carolina, Preda, Paola, Ruggeri, Deborah, Senese, Barbara, Chirumbolo, Gabriella, Martelli, Valeria, Urbini, Benedetta, Baccarani, Michele, Tura, Sante, Rondelli, Damiano

“…The aim of this study was to determine whether expression of the CD86 costimulatory molecule in acute myeloid leukemia (AML) can identify blast cells committed…”
Get full text

Allogeneic graft CD34 + cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant by Urbini, Benedetta, Arpinati, Mario, Bonifazi, Francesca, Chirumbolo, Gabriella, Falcioni, Sadia, Stanzani, Marta, Bandini, Giuseppe, Motta, Maria Rosa, Perrone, Giulia, Giannini, Benedetta, Tura, Sante, Baccarani, Michele, Rondelli, Damiano

“…This study examined whether the CD34 + cell dose in allografts correlates with the dose of myeloid dendritic cells (mDC) and plasmacytoid DC (pDC), and with DC…”
Get full text

Human CD34 + blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade by Arpinati, Mario, Terragna, Carolina, Chirumbolo, Gabriella, Rizzi, Simonetta, Urbini, Benedetta, Re, Francesca, Tura, Sante, Baccarani, Michele, Rondelli, Damiano

“…The immunogenic role of human CD34 + cells in allogeneic hematopoietic stem cell transplantation is controversial. In this study we tested the role of CD40 and…”
Get full text

Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 in allogeneic hematopoietic stem cell transplantation by Arpinati, M, Chirumbolo, G, Urbini, B, Martelli, V, Stanzani, M, Falcioni, S, Bonifazi, F, Bandini, G, Tura, S, Baccarani, M, Rondelli, D

“…TH2-inducing dendritic cells (DC2) are commonly identified as negative for lineage markers and positive for HLA-DR and CD123 expression. More recently, normal…”
Get full text

Acute graft-versus-host disease and steroid treatment impair CD11c + and CD123 + dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation by Arpinati, Mario, Chirumbolo, Gabriella, Urbini, Benedetta, Bonifazi, Francesca, Bandini, Giuseppe, Saunthararajah, Yogen, Zagnoli, Alessandra, Stanzani, Marta, Falcioni, Sadia, Perrone, Giulia, Tura, Sante, Baccarani, Michele, Rondelli, Damiano

“…Human dendritic cells (DC) comprise 2 subsets—plasmacytoid CD123 + and myeloid CD11c + DC—that may have distinct roles in the regulation of immunity after…”
Get full text

98 Infusion of high numbers of G-CSF mobilized blood dendritic cells type 2 (DC-2) is associated with an increased rate of chronic GVHD in allogeneic PBSC transplantation by Rondelli, D., Arpinati, M., Chirumbolo, G., Urbini, B., Bonifazi, F., Stanzani, M., Falcioni, S., Bandini, G., Baccarani, M.

Get full text

Method using urokinase and an antibiotic to avoid device removal in central venous catheter-related infections by Pession, Andrea, Castellini, Claudia, Prete, Arcangelo, Locatelli, Franco, Urbini, Benedetta, Paolucci, Guido

Get full text